I am a rare disease warrior. For 19 years, I kept it a secret. I was ashamed, in chronic pain, and every bit alone. It’s a relentless disease. It’s torture to the body. It’s absolute torment. I lived ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback